000 | 02593cam a22004571i 4500 | ||
---|---|---|---|
001 | 9781315102948 | ||
003 | FlBoTFG | ||
005 | 20220531132333.0 | ||
006 | m d | ||
007 | cr ||||||||||| | ||
008 | 191119s2019 flu o 000 0 eng d | ||
040 |
_aOCoLC-P _beng _erda _epn _cOCoLC-P |
||
020 |
_a9781315102948 _q(electronic bk.) |
||
020 |
_a1315102943 _q(electronic bk.) |
||
020 |
_a9781351593595 _q(ePub ebook) : |
||
020 |
_a1351593595 _q(ePub ebook) : |
||
020 | _z9781138103160 (hbk.) | ||
020 |
_a9781351593601 _q(PDF ebook) : |
||
020 |
_a1351593609 _q(PDF ebook) : |
||
020 |
_a9781351593588 _q(electronic bk. : Mobipocket) |
||
020 |
_a1351593587 _q(electronic bk. : Mobipocket) |
||
024 | 7 |
_a10.1201/9781315102948 _2doi |
|
035 | _a(OCoLC)1129692351 | ||
035 | _a(OCoLC-P)1129692351 | ||
050 | 4 | _aRS200 | |
082 | 0 | 4 |
_a615.19 _223 |
100 | 1 |
_aNiazi, Sarfaraz, _d1949- _eauthor. |
|
245 | 1 | 0 |
_aHandbook of pharmaceutical manufacturing formulations. _nVolume two, _pUncompressed solid products / _cSarfaraz K. Niazi. |
250 | _aThird edition. | ||
264 | 1 |
_aBoca Raton : _bCRC Press, _c2019. |
|
300 | _a1 online resource | ||
336 |
_atext _2rdacontent |
||
337 |
_acomputer _2rdamedia |
||
338 |
_aonline resource _2rdacarrier |
||
500 | _aPrevious edition: New York: Informa Healthcare, 2009. | ||
500 | _a<P><STRONG>Part I. Regulatory and Manufacturing Guidelines</STRONG></P><P>Chapter 1. U.S. FDA Good Manufacturing Practices</P><P>Chapter 2. Guideline on the Common Technical Document for the Registration of Pharmaceuticals for Human Use</P><P>Chapter 3. Process Validation: General Principles and Practices</P><P>Chapter 4. Bioequivalence Regulatory Compliance</P><P>Chapter 5. Bioequivalence Regulatory Review Process and Audit</P><P>Chapter 6. EU Guidelines to Good Manufacturing Practice: Active Drug Substance</P><P>Chapter 7. FDA Pre-approval Inspections</P><P>Chapter 8. Formulation Factors in Uncompressed Dosage Forms</P><P>Chapter 9: Solid-State Properties.</P><P>Chapter 10: Formulation of Flavor.</P><P><STRONG>Part II. Manufacturing Formulations</STRONG></P><P>Uncompressed Solids Formulations</P><P><STRONG>Part III. Commercial Pharmaceutical Formulations.</STRONG></P><P>Commercial Pharmaceutical Formulations.</P> | ||
588 | _aOCLC-licensed vendor bibliographic record. | ||
650 | 0 |
_aDrugs _xDosage forms. |
|
856 | 4 | 0 |
_3Taylor & Francis _uhttps://www.taylorfrancis.com/books/9781315102948 |
856 | 4 | 2 |
_3OCLC metadata license agreement _uhttp://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf |
999 |
_c70953 _d70953 |